Growth hormone receptor overexpression predicts response of rectal cancers to pre-operative radiotherapy
19265
post-template-default,single,single-post,postid-19265,single-format-standard,bridge-core-1.0.4,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-18.0.9,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-5.7,vc_responsive

Growth hormone receptor overexpression predicts response of rectal cancers to pre-operative radiotherapy

发表时间:2006-05-17 15:49

ABSTRACT

In this study, we evaluated the possible role of Growth Hormone Receptor (GHR) expression pattern in determining rectal cancer radiosensitivity. We examined GHR expression in pre- treatment biopsy materials and post-operative specimens from 98 patients by immunohis- tochemistry (IHC) and reverse transcription-polymerase chain reaction (RT-PCR). GHR expression was evaluated for association with tumour radiosensitivity, which was defined according to Rectal Cancer Regression Grade (RCRG). IHC results demonstrated that GHR overexpression was significantly associated with a poor response to radiotherapy (P < 0.001, r s = 0.399); RT-PCR detection of GHR expression on pre-radiation biopsy speci- mens also showed that GHR mRNA negative group had a higher radiation sensitivity (P < 0.001, r s = 0.398). Compared with the pre-radiation biopsy specimens, the paired post- operative specimens showed a significantly up-regulated GHR expression in the reliquus cancer cells (P < 0.001). In conclusion, GHR expression levels may be an indicator for rectal cancer radiosensitivity before pre-operative irradiation. The administration of GHR antag- onist may have the potential to increase rectal cancer radiosensitivity.

第一署名医院:南京军区南京总医院

Growth hormone receptor overexpression predicts response of rectal cancers to pre-operative radiotherapy(查看pdf)